EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Neuroprotective Effect of the X Protein of Orthobornavirus Bornaense Type 1 in Amyotrophic Lateral Sclerosis

Jeflie Tournezy iD, Claire Léger, Bernard Klonjkowski iD, Daniel Gonzalez-Dunia iD, Marion Szelechowski iD, André Garenne, Stéphane Mathis, Stéphanie Chevallier iD, Gwendal Le Masson

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252312789 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Jeflie Tournezy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Neurocentre Magendie INSERM U1215, Université de Bordeaux, 33000 Bordeaux, France. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Motor Neurons, Neuroprotective Agents, Disease Models, Animal. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Association pour la recherche sur la Sclérose Latérale Amyotrophique, Fondation pour la Recherche Médicale, Association Francaise contre les Myopathies.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In amyotrophic lateral sclerosis (ALS), early mitochondrial dysfunction may contribute to progressive motor neuron loss. Remarkably, the ectopic expression of the Orthobornavirus bornaense type 1 (BoDV-1) X protein in mitochondria blocks apoptosis and protects neurons from degeneration. Therefore, this study examines the neuroprotective effects of X protein in an ALS mouse model. We first tested in vitro the effect of the X-derived peptide (PX3) on motoneurons primary cultures of SOD1G93A mice. The total intracellular adenosine triphosphate (ATP) content was measured after incubation of the peptide. We next tested in vivo the intramuscular injection of X protein using a canine viral vector (CAV2-X) and PX3 intranasal administrations in SOD1G93A mice. Disease onset and progression were assessed through rotarod performance, functional motor unit analysis via electrophysiology, and motor neuron survival by immunohistochemistry. The results showed that in vitro PX3 restored the ATP level in SOD1G93A motor neurons. In vivo, treated mice demonstrated better motor performance, preserved motor units, and higher motor neuron survival. Although life expectancy was not extended in this severe mouse model of motor neuron degeneration, the present findings clearly demonstrate the neuroprotective potential of X protein in a model of ALS. We are convinced that further studies may improve the therapeutic impact of X protein with optimized administration methods.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisMotor NeuronsNeuroprotective AgentsDisease Models, AnimalAnimalsMiceAdenosine TriphosphateViral ProteinsMice, TransgenicHumans

Stichwörter der Autor:innen

ALSBoDV-1SOD1G93A miceX proteinmitochondria

Substanzen

Neuroprotective AgentsAdenosine TriphosphateViral Proteins

Autor:innen und Institutionen

  • Neurocentre Magendie INSERM U1215, Université de Bordeaux, 33000 Bordeaux, France.
  • UMR 1161 Virologie, INRA, ANSES, Ecole Nationale Vétérinaire d'Alfort, 94700 Maisons-Alfort, France.
  • Infinity (Toulouse Institute for Infectious and Inflammatory Diseases), INSERM, CNRS, Université de Toulouse, UPS, 31024 Toulouse, France.
  • IMS Laboratory, UMR5218, CNRS, Bordeaux University, 33400 Talence, France.
  • Nerve-Muscle Unit, ALS Center, Department of Neurology, University Hospital (CHU) of Bordeaux (Pellegrin Hospital), 33000 Bordeaux, France.

ORCID-Profile: Jeflie Tournezy, Bernard Klonjkowski, Daniel Gonzalez-Dunia, Marion Szelechowski, Stéphanie Chevallier

Förderung

  • Association pour la recherche sur la Sclérose Latérale Amyotrophique
  • Fondation pour la Recherche Médicale
  • Association Francaise contre les Myopathies
  • Rotary Club of Bergerac
  • Association for research on ALS (ARSLA)
  • AFM-Téléthon (Association Française pour la Myopathie)
  • Rotary Club of Bergerac, France

Zitieren

APA

Tournezy, J., Léger, C., Klonjkowski, B., Gonzalez-Dunia, D., Szelechowski, M., Garenne, A., Mathis, S., Chevallier, S., & Le Masson, G. (2024). The Neuroprotective Effect of the X Protein of Orthobornavirus Bornaense Type 1 in Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312789

Vancouver

Tournezy J, Léger C, Klonjkowski B, Gonzalez-Dunia D, Szelechowski M, Garenne A, et al. The Neuroprotective Effect of the X Protein of Orthobornavirus Bornaense Type 1 in Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312789

BibTeX
@article{Tournezy2024,
  author = {Tournezy, Jeflie and Léger, Claire and Klonjkowski, Bernard and Gonzalez-Dunia, Daniel and Szelechowski, Marion and Garenne, André and Mathis, Stéphane and Chevallier, Stéphanie and Le Masson, Gwendal},
  title = {The Neuroprotective Effect of the X Protein of Orthobornavirus Bornaense Type 1 in Amyotrophic Lateral Sclerosis},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252312789}
}
Kostenlos starten →